orchid pharma faces liquidation as lenders reject resolution plan
.experts say years of cuts to nhs budgets and staff has led to patients waiting longer for chemotherapy and radiotherapy (file pic)
.: "fremanezumab for the preventive treatment of chronic migraine."
.
.
david dodick, md, neurologist, mayo clinic; chairman, american migraine foundation.
.
.
.